With the significant decrease in the sequencing costs and rising investments in the pharmaceutical industry, the global genomics market is forecast to grow at a CAGR of 15.1% to be worth $19,938.6 million by 2020. This growth is further driven by the technological innovations in bioinformatics, increasing clinical capabilities, and more clinically relevant sequencing timescales. However, need of significant clinical investment, lack of funding in the emerging markets, rising consolidation mainly in the instruments market, and ethical and legal challenges will act as a constraint to industry growth during the forecast period.
The global genomics market is segmented by methods, technology, instruments, consumables, services, and geography. The genomics industry is still at a nascent stage with many untapped markets present across the globe. However, the sequencing method is relatively at a mature stage, especially, in the developed markets. As, the scale of genomes data grows, the data analysis and interpretation market is expected to grow at a significant rate in the near future.
Next-generation DNA sequencing (NGS) technology has transformed biomedical research, making genome and RNA sequencing an affordable and commonly used tool for a wide variety of research applications. As a result, the market has been stressed to manage the enormous data output from this process. Therefore, the complexity and sheer amount of data generated by NGS has led to a need for genomic centers to form bioinformatics teams in order to analyze the output data.
North America is the major market in the global genomics market and is expected to dominate this market during the forecast period, with the U.S. contributing a major share, followed by Europe, and Asia-Pacific. On the other hand, the Asian market, especially India and China, is expected to witness a boost in demand for genomics market during the forecast period, as a result of their economic development, increasing genetic research and development activities, drastically reduced mass scale genetic testing costs, and the growing focus of the major players in this region.
The key players in the global genomics market are Affymetrix, Inc., Agilent Technologies, BGI (Beijing Genomics Institute), Illumina, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Cepheid, GE Healthcare, Qiagen N.V, Roche Holding AG, Pacific Biosciences of California, Inc., Oxford Nanopore Technologies Ltd., Beckman Coulter Genomics, Inc., Perkin Elmer, Inc., DNASTAR, Inc, Genomatix Software Gmbh, and GenoLogics Life Sciences Software, Inc.,
The global genomics market is segmented by methods, technology, instruments, consumables, services, and geography:
- Nucleic acid Extraction & Purification
- NGS Platforms
- DNA Microarrays
- Nucleic acid Extraction and Purification Systems
- DNA Sequencers
- Pacific Biosciences
- DNA Sequencing
- Nucleic acid extraction and purification systems
- Laboratory Services
Genomics Market, By Geography:
- North America
-- Rest of Europe
-- Rest of Asia-Pacific
- Rest of the World
-- Latin America
-- Middle East and Africa
Key Questions Answered in the Report:
Which are the high growth market segments in terms of genomics instruments, methods, consumables, services, regions, and countries?
What is the historical market for genomics across the globe?
What are the market forecasts and estimates from the period 2015-2020?
What are the major drivers, restrains, threats, and opportunities in the global genomics market?
What are the burning issues of the global genomics market?
Who are the major players in the global genomics market and what share of the market do they hold?
Who are the major players in various regions (North America, APAC, Europe) and what share of the market do they hold?
What are the competitive landscapes and who are the market leaders by sub-region in the global genomics market?
What are the recent developments in the global genomics market?
What are the different strategies adopted by the major players in the global genomics market?
What are the geographical trends and high growth regions?
1.1 Genomics Market Ecosystem
1.2 Report Elucidation
1.3 Market Buzz and Foreground
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Market Size Estimation
1.4.3 Market Size Forecast
1.4.4 Primary Research Sampling Frame
2. Executive Summary
3. Market Insights
3.1 Key Drivers
3.2 Key Restraints
3.3 Key Opportunities
3.4 Key Challenges
4. Market Share Analysis
5. Global Genomics - Market Crackdown ($ Value Analysis), By Method
6. Global Genomics - Market Crackdown ($ Value Analysis), By Technology
6.2 Sequencing Technology
6.3 Microarray Technology
6.4 Nucleic Acid Extraction & Purification Technology
7. Global Genomics Instruments - Market Crackdown ($ Value Analysis), By Type
7.2 NGS Platforms
7.2.4 Pacific Biosciences
7.3 DNA Microarrays
7.4 Nucleic acid extraction and purification systems
7.5 DNA Sequencers
8. Global Genomics Consumables - Market Crackdown ($ Value Analysis), By Type
8.2 DNA Sequencing
8.3 Nucleic acid extraction and purification systems
9. Global Genomics Services - Market Crackdown ($ Value Analysis),By Type
9.1 Laboratory Services
10. Genomics - Market Crackdown ($ Value Analysis),By Geography
10.1 North America
10.4.1 Latin America
10.4.2 Middle East & Africa
11. Global Genomics Market - Competitive Landscape
11.1 New Product Launches
11.2 Mergers and Acquisitions
11.3 Agreements and Partnerships
11.5 Other Developments
12. Company Profiles
12.1 Affymetrix, Inc.
12.2 Agilent Technologies
12.3 BGI (Beijing Genomics Institute)
12.4 Illumina, Inc.
12.5 Thermo Fisher Scientific, Inc.
12.6 Bio-Rad Laboratories, Inc.
12.8 GE Healthcare
12.9 Qiagen N.V
12.10 Roche Holding AG
12.11 Pacific Biosciences of California, Inc.
12.13 Oxford Nanopore Technologies Ltd.
12.14 Beckman Coulter Genomics, Inc.
12.15 Perkin Elmer, Inc
12.16 DNASTAR, Inc,
12.17 Genomatix Software Gmbh
12.18 GenoLogics Life Sciences Software, Inc
- Agilent Technologies
- BGI (Beijing Genomics Institute)
- Beckman Coulter Genomics, Inc.
- Bio-Rad Laboratories, Inc.
- DNASTAR, Inc,
- GE Healthcare
- GenoLogics Life Sciences Software, Inc
- Genomatix Software Gmbh
- Illumina, Inc.
- Oxford Nanopore Technologies Ltd.
- Pacific Biosciences of California, Inc.
- Perkin Elmer, Inc
- Qiagen N.V
- Roche Holding AG
- Thermo Fisher Scientific, Inc.